Phyllome
11 employees on LinkedIn · 1 known investors
Phyllome grows edible plants engineered to express cyclotide therapeutic peptides, turning them into functional foods with controlled therapeutic dosing as an oral alternative to injected or synthetic drugs. Its pipeline targets analgesic, cholesterol-modulating, and appetite-regulating applications, developed with the University of Queensland's Institute for Molecular Bioscience.
Founders & leadership
SE
Sebastien Eckersley-MaslininFounder and CEO
Investors · 1
Frequently asked questions
- What does Phyllome do?
- Phyllome grows edible plants engineered to express cyclotide therapeutic peptides, turning them into functional foods with controlled therapeutic dosing as an oral alternative to injected or synthetic drugs. Its pipeline targets analgesic, cholesterol-modulating, and appetite-regulating applications, developed with the University of Queensland's Institute for Molecular Bioscience.
- Who founded Phyllome?
- Phyllome was founded by Sebastien Eckersley-Maslin.
- Who are Phyllome's investors?
- Phyllome's investors include Tenacious Ventures.